Literature DB >> 28341259

Effect of vitamin D supplementation and isokinetic training on muscle strength, explosive strength, lean body mass and gait in severely burned children: A randomized controlled trial.

Anwar Abdelgayed Ebid1, Shamekh Mohamed El-Shamy2, Maysa Abbas Amer3.   

Abstract

OBJECTIVE: To determine the effects of vitamin D (VD) supplementation and isokinetic training on muscle strength, explosive strength (counter movement jump) (ES), lean body mass (LBM) and gait parameters in severe pediatric burn.
METHODS: Forty-eight burned children with circumferential lower extremity burns covering 40-55% of the total body surface area (TBSA), aged 10-16 years (Mean±SD 13.01±1.75), were randomized into the standard of care (n=16), isokinetic (n=17) and VD (n=15) groups. Unburned children (n=20) served as matched controls. All burned children received 12 weeks of routine physical therapy program (RPTP). In addition, the isokinetic group received isokinetic training for the quadriceps dominant limb 3 times per week at angular velocity 150°/s, and the VD group received the isokinetic training plus an oral daily dose of vitamin D3 1000 IU (Cholecalciferol). The primary measures, assessed at baseline and 12 weeks, included quadriceps strength by isokinetic dynamometer, ES, LBM by dual-energy X-ray absorptiometry (DEXA) and gait parameters by GAITRite system.
RESULTS: The VD and isokinetic groups showed significant improvement in quadriceps strength, ES, LBM and gait parameters compared with the standard of care, and VD group show significant improvement in the VD level as compared with the other groups. The outcome measures (and percent of improvement where applicable) for the VD, isokinetic and standard of care are as follows: quadriceps strength, 85.25±0.93Nm (85%), 64.25±0.93 (36%) and 51.88±1.31Nm (12%); stride length, 94.00±2.69 (7%), 110.60±2.87 (25%) and 139.56±2.57 (60%); step length, 67.26±2.45 (72%), 55.25±2.49 (43%) and 43.76±1.34 (18%); velocity, 133.94±1.65 (82%), 99.94±1.65 (35%) and 80.11±1.91 (9%); and cadence, 140.63±1.36 (68%), 132.63±1.36 (58%) and 90.35±1.32 (9%), VD level 43.33±7.48 (75%), 24.77±7.38 (5%) and 25.63±8.39 (4%) respectively.
CONCLUSIONS: VD supplementation combined with exercise training significantly increased muscle strength, ES, LBM, gait and VD level in severely burned children. Copyright Â
© 2016 Elsevier Ltd and ISBI. All rights reserved.

Entities:  

Keywords:  Gait; Isokinetic; Pediatric burn; Rehabilitation; Vitamin D

Mesh:

Substances:

Year:  2016        PMID: 28341259     DOI: 10.1016/j.burns.2016.08.018

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  5 in total

1.  Description of Bone Health Changes in a Cohort of Children With Acute Flaccid Myelitis (AFM).

Authors:  Natalie Curley; Yilin Yang; Janet Dean; Cynthia Salorio; Cristina Sadowsky
Journal:  Top Spinal Cord Inj Rehabil       Date:  2022-01-19

Review 2.  The effects of resistance training on children with burns: a meta-analysis.

Authors:  Sha Yang; Lin Qiu; Jun Xiao; Cong Luo
Journal:  Pediatr Surg Int       Date:  2021-07-30       Impact factor: 1.827

3.  The role of serum levels of vitamin D in children's muscle strength: A systematic review.

Authors:  Ana B J da Silva; Taciane S do Carmo; Ana P S Souza; Mariluce R M Silva; Matheus S S Fernandes; Viviane O N Souza; Waleska M A Barros
Journal:  Clinics (Sao Paulo)       Date:  2021-09-20       Impact factor: 2.365

4.  Effects of High-Dose Vitamin D Supplementation on Phase Angle and Physical Function in Patients with Prostate Cancer on ADT.

Authors:  Julia E Inglis; Isabel D Fernandez; Edwin van Wijngaarden; Eva Culakova; Jennifer E Reschke; Amber S Kleckner; Po-Ju Lin; Karen M Mustian; Luke J Peppone
Journal:  Nutr Cancer       Date:  2020-09-11       Impact factor: 2.900

Review 5.  Oral Nutrition during and after Critical Illness: SPICES for Quality of Care!

Authors:  Marjorie Fadeur; Jean-Charles Preiser; Anne-Marie Verbrugge; Benoit Misset; Anne-Françoise Rousseau
Journal:  Nutrients       Date:  2020-11-14       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.